The increased deposition of extracellular matrix by hepatic stellate cells following liver injury, in a process known as activation, is considered a key mechanism for increased
collagen content of liver during the development of
liver fibrosis. We report that
N-(methylamino)isobutyric acid (
MeAIB), a specific inhibitor of System A-mediated
amino acid uptake, reduces the accumulation of
collagen in CFSC-2G hepatic stellate cell cultures and in a rat model of liver injury and
fibrosis. Rat CFSC-2G cells were cultured in 0-5mM
MeAIB, and the accumulation and synthesis of
collagen were measured by binding to
Sirius red F3B and pulse-labeling with [3H]-
proline, respectively. The effect of
MeAIB on
collagen accumulation in vivo was evaluated utilizing a rat model of hepatic
fibrosis.
MeAIB inhibited
collagen accumulation in CFSC-2G cultures in a concentration-dependent manner with 5mM
MeAIB reducing
collagen 44.6+/-1.2% compared with the control. In CFSC-2G cultures,
MeAIB selectively inhibited the incorporation of
proline into cellular macromolecules by 43+/-4%, while the synthesis of
proteins containing
leucine was not affected. In vivo,
oral administration of 160mg
MeAIB/kg
body weight per day to rats significantly reduced the hepatic
collagen accumulation in response to 1 week of CCl(4)-induced liver injury.
MeAIB reduces the accumulation of
collagen in CFSC-2G hepatic stellate cell cultures and in a CCl(4)-induced rat model of liver injury and
fibrosis.